68071-3268 Ondansetron

Product NDC:

68071-3268

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: Ondansetron

Strength: 4.0

Unit: mg/1

Packages:

Code: 68071-3268-01

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-1)

Effective Date: May 23, 2017

Discontinued:

Code: 68071-3268-02

Description: 2 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-2)

Effective Date: May 23, 2017

Discontinued:

Code: 68071-3268-07

Description: 20 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-7)

Effective Date: May 23, 2017

Discontinued:

Code: 68071-3268-03

Description: 3 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-3)

Effective Date: May 23, 2017

Discontinued:

Code: 68071-3268-04

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-4)

Effective Date: May 23, 2017

Discontinued:

Code: 68071-3268-06

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-6)

Effective Date: May 23, 2017

Discontinued:

Code: 68071-3268-05

Description: 5 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (68071-3268-5)

Effective Date: May 23, 2017

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC